MEKTARA Trademark

Trademark Overview


On Thursday, April 21, 2011, a trademark application was filed for MEKTARA with the United States Patent and Trademark Office. The USPTO has given the MEKTARA trademark a serial number of 85301359. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 10, 2012. This trademark is owned by Glaxo Group Limited. The MEKTARA trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the tre...
mektara

General Information


Serial Number85301359
Word MarkMEKTARA
Filing DateThursday, April 21, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 10, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2011

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 25, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiddlesex UB060NN

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiddlesex UB060NN

Trademark Events


Event DateEvent Description
Monday, December 10, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 10, 2012ABANDONMENT - NO USE STATEMENT FILED
Friday, April 6, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 4, 2012EXTENSION 1 GRANTED
Wednesday, April 4, 2012EXTENSION 1 FILED
Wednesday, April 4, 2012TEAS EXTENSION RECEIVED
Tuesday, November 8, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 13, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2011PUBLISHED FOR OPPOSITION
Tuesday, August 9, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 8, 2011ASSIGNED TO LIE
Tuesday, July 26, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 12, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 12, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 12, 2011TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, July 6, 2011NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 6, 2011LETTER OF SUSPENSION E-MAILED
Wednesday, July 6, 2011SUSPENSION LETTER WRITTEN
Thursday, June 30, 2011ASSIGNED TO EXAMINER
Monday, April 25, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 25, 2011NEW APPLICATION ENTERED IN TRAM